Short-term effects of naltrexone in 155 heroin ex-addicts
- PMID: 999987
Short-term effects of naltrexone in 155 heroin ex-addicts
Abstract
The narcotic antagonist naltrexone was administered for periods of up to 8 months to a total of 155 patients at a dose of 40-200 mg per day. The antagonistic effect of naltrexone was tested by injections of heroin. Eighty milligrams of natrexone was effective for 48hr. The antagonistic effect decreased at 72 hr after the administration of 120-200 mg of naltrexone. Laboratory tests indicated no signs of toxicity. Naltrexone may elicit an increase in blood pressure and opigastric pain. Neither of these side effects appear clinically important. No signs of dependence on naltrexone were detected. These results suggest that naltrexone may be useful for clinical treatment of opiate dependence.
Similar articles
-
Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.Arch Gen Psychiatry. 1978 Mar;35(3):335-40. Arch Gen Psychiatry. 1978. PMID: 365122 Clinical Trial.
-
Naltrexone: a clinical perspective.J Clin Psychiatry. 1984 Sep;45(9 Pt 2):25-8. J Clin Psychiatry. 1984. PMID: 6469933
-
Five-year follow-up of opiate addicts with naltrexone and behavior therapy.NIDA Res Monogr. 1984 Mar;49:289-95. NIDA Res Monogr. 1984. PMID: 6434974
-
Review of naltrexone, a long-acting opiate antagonist.Clin Pharm. 1984 May-Jun;3(3):273-80. Clin Pharm. 1984. PMID: 6329589 Review.
-
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.Addict Biol. 2004 Mar;9(1):81-7. doi: 10.1080/13556210410001674130. Addict Biol. 2004. PMID: 15203443 Review.
Cited by
-
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.Drugs. 1988 Mar;35(3):192-213. doi: 10.2165/00003495-198835030-00002. Drugs. 1988. PMID: 2836152 Review.
-
Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. CNS Neurosci Ther. 2011. PMID: 21554565 Free PMC article.
-
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation.Health Justice. 2020 Mar 14;8(1):7. doi: 10.1186/s40352-020-0106-9. Health Justice. 2020. PMID: 32172481 Free PMC article.
-
Maintenance medication for opiate addiction: the foundation of recovery.J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. J Addict Dis. 2012. PMID: 22873183 Free PMC article. Review.
-
Contemporary clinical opioid use: opportunities and challenges.Mayo Clin Proc. 2009 Jul;84(7):572-5. doi: 10.1016/S0025-6196(11)60744-1. Mayo Clin Proc. 2009. PMID: 19567709 Free PMC article. No abstract available.